These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7901397)

  • 1. Multiple spinal mediators in parenteral nicotine-induced antinociception.
    Rogers DT; Iwamoto ET
    J Pharmacol Exp Ther; 1993 Oct; 267(1):341-9. PubMed ID: 7901397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus.
    Iwamoto ET
    J Pharmacol Exp Ther; 1991 Apr; 257(1):120-33. PubMed ID: 1673472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1993 May; 265(2):777-89. PubMed ID: 8388459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.
    Iwamoto ET
    J Pharmacol Exp Ther; 1989 Nov; 251(2):412-21. PubMed ID: 2810106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1994 May; 269(2):699-708. PubMed ID: 7514222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociception produced by oral, subcutaneous or intrathecal administration of SC-39566, an opioid dipeptide arylalkylamide, in the rodent.
    Hammond DL; Stapelfeld A; Drower EJ; Savage MA; Tam L; Mazur RH
    J Pharmacol Exp Ther; 1994 Feb; 268(2):607-15. PubMed ID: 8113971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1994 Nov; 271(2):601-8. PubMed ID: 7965774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1993 Jul; 266(1):329-38. PubMed ID: 8101218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic and alpha(1)-adrenergic mechanisms contribute to the spinal mediation of stimulation-induced antinociception from the pedunculopontine tegmental nucleus in the rat.
    Dias QM; Crespilho SF; Silveira JW; Prado WA
    Pharmacol Biochem Behav; 2009 May; 92(3):488-94. PubMed ID: 19463264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ciprofloxacin and gentamicin on spinal morphine-induced antinociception in rats.
    Luger TJ; Farkas W; Geisler H; Lorenz IH
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):366-74. PubMed ID: 15853929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice.
    Kiguchi N; Maeda T; Tsuruga M; Yamamoto A; Yamamoto C; Ozaki M; Kishioka S
    Brain Res; 2008 Jan; 1189():70-7. PubMed ID: 18048009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intrathecal 6-hydroxydopamine, alpha1 and alpha2 adrenergic receptor antagonists on antinociception of propofol in mice.
    Ge ZJ; Zeng YM; Tan YF
    Acta Pharmacol Sin; 2005 Feb; 26(2):186-91. PubMed ID: 15663897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effects of bethanechol or dimethylphenylpiperazinium in models of phasic or incisional pain in rats.
    Prado WA; Segalla DK
    Brain Res; 2004 Aug; 1018(2):272-82. PubMed ID: 15276888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E; Bagdas D; Gurun MS
    Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of neurotensin in the nucleus raphe magnus in opioid-induced antinociception from the periaqueductal gray.
    Urban MO; Smith DJ
    J Pharmacol Exp Ther; 1993 May; 265(2):580-6. PubMed ID: 8496808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
    Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
    Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
    Welch SP; Dunlow LD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):390-9. PubMed ID: 8229767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.